Thyroid cancer after childhood exposure to external radiation: An updated pooled analysis of 12 studies

Radiation Research

Volumn 185, Issue 5, 2016, Pages 473-484

  Veiga, Lene H S ^a,b   Holmberg, Erik ^c   Anderson, Harald ^d,e   Pottern, Linda ^f   Sadetzki, Siegal ^g   Adams, M Jacob ^h   Sakata, Ritsu ⁱ   Schneider, Arthur B ^j   Inskip, Peter ^a   Bhatti, Parveen ^k   Johansson, Robert ^l   Neta, Gila ^a   Shore, Roy ⁱ   De Vathaire, Florent ^m   Damber, Lena ^l   Kleinerman, Ruth ^a   Hawkins, Michael M ⁿ   Tucker, Margaret ^a   Lundell, Marie ^o   Lubin, Jay H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Brazilian Nuclear Energy Commission   (Brazil)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e Representing the Nordic Countries Childhood Cancer Survival Group   (United States)

^f U S PUBLIC HEALTH SERVICE   (United States)

^g TEL AVIV UNIVERSITY   (Israel)

^h UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

ⁱ RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^j UNIVERSITY OF ILLINOIS   (United States)

^k USA   (United States)

^l UMEÅ UNIVERSITY   (Sweden)

^m INSERM   (France)

ⁿ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^o KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION RESPONSE; SEX DIFFERENCE; THYROID CANCER; INFANT; META ANALYSIS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEWBORN; THYROID NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84971450011     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR14213.1     Document Type: Article

References (45)

1. Ron E, Schneider AB. Thyroid Cancer. In: Schottenfeld D, Fraumeni Jr. JF, editors. Cancer epidemiology and prevention. 3rd ed. New York, Oxford University Press, Inc.; 2006. p. 975-94.
2. UNSCEAR, Sources and Effects of Ionizing Radiation 2013 Report to the General Assembly, with Scientific Annexes. New York: United Nations Publications; 2013.
3. Saad AG, Kumar S, Ron E, Lubin JH, Stanek J, Bove KE, et al. Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. J Clin Endocrinol Metab. 2006; 91: 2672-7.
4. Ron E, Lubin JH, Shore R, Mabuchi K, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiation - A pooled analysis of 7 studies. Radiat Res. 1995; 141: 259-77.
5. Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, de Vathaire F, et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol. 2013; 31: 119-27.
6. Veiga LHS, Bhatti P, Ronckers CM, Sigurdson AJ, Stoval M, Smith SA, et al. Chemotherapy and thyroid cancer risk: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2012; 21: 92-101.
7. Bhatti P, Veiga LHS, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 174; 2010: 741-52.
8. Veiga LH, Lubin JH, Anderson H, de Vathaire F, Tucker M, Bhatti P, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res. 2012; 178: 365-76.
9. Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, de Vathaire F, Olsen JH, et al. Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: A population-based casecontrol study in the five Nordic countries. Acta Oncol. 2006; 45: 438-48.
10. Tucker MA, Jones PHM, Boice JD, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res. 1991; 51: 2885-8.
11. de Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, et al. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med. 1999; 159: 2713-9.
12. Adams MJ, Shore RE, Dozier A, Lipshultz SE, Schwartz RG, Constine LS, et al. Thyroid cancer risk 40θ years after irradiation for an enlarged thymus: an update of the Hempelmann Cohort. Radiat Res. 2010; 174: 753-62.
13. Sadetzki S, Chetrit A, Lubina A, Stovall M, Novikov I. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab. 2006; 91: 4798-804.
14. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res. 1989; 120: 516-31.
15. Ron E, Modan B. Benign and malignant thyroid neoplasms after childhood irradiation for tinea capitis. J Natl Cancer Inst. 1980; 65: 7-11.
16. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC. Doseresponse relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab. 1993; 77: 362-9.
17. Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Schneider AB. Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome. J Clin Endocrinol Metab. 2002; 87: 3236-41.
18. Pottern LM, Kaplan MM, Larsen PR, Silva JE, Koenig RJ, Lubin JH, et al. Thyroid nodularity after childhood irradiation for lymphoid hyperplasia - A comparison of questionnaire and clinical findings. J Clin Epidemiol. 1990; 43: 449-60.
19. Eidemueller M, Holmberg E, Jacob P, Lundell M, Karlsson P. Breast cancer risk after radiation treatment at infancy: potential consequences of radiation-induced genomic instability. Radiat Prot Dosimetry. 2011; 143: 375-9.
20. Furst CJ, Lundell M, Holm LE, Silfversward C. Cancer incidence after radiotherapy for skin hemangioma - A retrospective cohort study in Sweden. J Natl Cancer Inst. 1988; 80: 1387-92.
21. Lundell M, Hakulinen T, Holm LE. Thyroid cancer after radiotherapy for skin hemangioma in infancy. Radiat Res. 1994; 140: 334-9.
22. Lindberg S. Radiotherapy of childhood haemangiomas: From active treatment to radiation risk estimates. Radiat Environ Biophys. 2001; 40: 179-89.
23. Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lundberg LM, Wallgren A. Cancer incidence after radiotherapy for skin hemangioma during infancy. Acta Oncologica. 1995; 34: 735-40.
24. Haddy N, Andriamboavonjy T, Paoletti C, Dondon MG, Mousannif A, Shamsaldin A, et al. Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy. Radiother Oncol. 2009; 93: 377-82.
25. Shamsaldin A, Lundell M, Diallo I, Ligot L, Chavaudra J, de Vathaire F. Estimation of the radiation dose from radiotherapy for skin haemangiomas in childhood: the ICTA software for epidemiology. Phys Med Biol. 2000; 45: 3589-99.
26. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007; 168: 1-64.
27. Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S, et al. Long-Term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer. 2013; 132: 1222-6.
28. Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990; 5: 46-51.
29. Schisterman EF, Vexler A, Whitcomb BW, Liu AY. The limitations due to exposure detection limits for regression models. Am J Epidemiol. 2006; 163: 374-83.
30. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect. 2004; 112: 1691-6.
31. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure users guide. Seattle: HiroSoft International Corporation; 2008.
32. Dersimonian R, Laird N. Metaanalysis in clinical-Trials. Control Clin Trials. 1986; 7: 177-88.
33. DerSimonian R, Kacker R. Random-effects model for metaanalysis of clinical trials: An update. Contemp Clin Trials. 2007; 28: 105-14.
34. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med. 2002; 21: 1539-58.
35. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A. 2005; 102: 13040-5.
36. UNSCEAR, Effects of Ionizing Radiation, 2006 Report to the General Assembly, with Scientific Annexes. New York: United Nations Publications; 2006.
37. Challeton C, Branea F, Schlumberger M, Gaillard N, DeVathaire F, Badie C, et al. Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys. 1997; 37: 163-9.
38. Ron E. Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys. 2007; 93: 502-11.
39. Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D. Thyroid cancer after Chernobyl. Nature. 1992; 359: 21-2. (Scientific Correspondence).
40. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature. 1992; 359: 21-1. (Scientific Correspondence).
41. Heidenreich WF, Bogdanova TI, Biryukov AG, Tronko ND. Time trends of thyroid cancer incidence in Ukraine after the Chernobyl accident. J Radiol Prot. 2004; 24: 283-93.
42. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested casecontrol study. Lancet. 2005; 365: 2014-23.
43. Shore RE. Issues and epidemiologic evidence regarding radiationinduced thyroid cancer. Radiat Res. 1992; 131: 98-111.
44. Lubin JH, Schafer DW, Ron E, Stovall M, Carroll RJ. A reanalysis of thyroid neoplasms in the Israeli Tinea Capitis Study accounting for dose uncertainties. Radiat Res. 2004; 161: 359-68.
45. Schafer DW, Lubin JH, Ron E, Stovall M, Carroll RJ. Thyroid cancer following scalp irradiation: A reanalysis accounting for uncertainty in dosimetry. Biometrics. 2001; 57: 689-97.